Considering that acute respiratory distress syndrome due to COVID-19 pneumonia develops very aggressively and rapidly, it can be said that measuring serum long PTX-3 levels has been proposed to be a marker for early diagnosis in order to predict the progression of the disease. The gene discussed is PTX3; the disease is acute respiratory distress syndrome.